title: Limited impact of EU paediatric regulation on Finnish clinical trials highlights need for Nordic collaboration.
abstract: The Finnish Investigators Network for Paediatric Medicines (FINPEDMED) was established in 2007, to meet the expected increase in paediatric clinical trials following the new EU Paediatric Regulation. Between 2007 and 2012, FINPEDMED received 91 trial requests, 18 trials were started, and in 24 cases, Finnish investigators were not selected by sponsors.
  
  
  CONCLUSIONS
  This experience from Finland highlights the need for Nordic collaboration to increase expertise, recruitment base and attractiveness for sponsors.
authors.affiliation: Tampere Center for Child Health Research, Tampere University and University Hospital, Tampere, Finland. matti.korppi@uta.fi.
authors.forename: Matti
authors.initials: M
authors.lastname: Korppi
authors.forename: Pirkko
authors.initials: P
authors.lastname: Lepola
authors.forename: Kim
authors.initials: K
authors.lastname: Vettenranta
authors.forename: Seppo
authors.initials: S
authors.lastname: Pakkala
authors.forename: Kalle
authors.initials: K
authors.lastname: Hoppu
mesh_terms: D002986:Clinical Trials as Topic / Q000639:trends*; D005062:European Union; D005387:Finland; D010372:Pediatrics / Q000331:legislation & jurisprudence / Q000639:trends*
keywords: Clinical trial; EU regulation; Paediatric medicines; Research network